Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.

Glasgow CG, Avila NA, Lin JP, Stylianou MP, Moss J.

Chest. 2009 May;135(5):1293-300. doi: 10.1378/chest.08-1160.

2.

Lymphatic involvement in lymphangioleiomyomatosis.

Glasgow CG, Taveira-Dasilva AM, Darling TN, Moss J.

Ann N Y Acad Sci. 2008;1131:206-14. doi: 10.1196/annals.1413.018. Review.

3.

Lymphatic manifestations of lymphangioleiomyomatosis.

Gupta R, Kitaichi M, Inoue Y, Kotloff R, McCormack FX.

Lymphology. 2014 Sep;47(3):106-17. Review.

PMID:
25420303
4.

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Glasgow CG, El-Chemaly S, Moss J.

Eur Respir Rev. 2012 Sep 1;21(125):196-206. doi: 10.1183/09059180.00009311. Review.

5.

Lymphangioleiomyomatosis: a disease involving the lymphatic system.

Seyama K, Kumasaka T, Kurihara M, Mitani K, Sato T.

Lymphat Res Biol. 2010 Mar;8(1):21-31. doi: 10.1089/lrb.2009.0018. Review.

PMID:
20235884
6.

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

Clin Epidemiol. 2015 Apr 7;7:249-57. doi: 10.2147/CLEP.S50780. eCollection 2015. Review.

7.

Lymphangioleiomyomatosis: differential diagnosis and optimal management.

Xu KF, Lo BH.

Ther Clin Risk Manag. 2014 Aug 21;10:691-700. doi: 10.2147/TCRM.S50784. eCollection 2014. Review.

8.

Clinical and molecular insights into lymphangioleiomyomatosis.

Steagall WK, Taveira-DaSilva AM, Moss J.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S49-66. Review.

PMID:
16457017
9.

Lymphangioleiomyomatosis: New Treatment Perspectives.

Radzikowska E.

Lung. 2015 Aug;193(4):467-75. doi: 10.1007/s00408-015-9742-6. Epub 2015 May 17. Review.

PMID:
25980593
10.

Lymphangioleiomyomatosis.

Taveira-DaSilva AM, Steagall WK, Moss J.

Cancer Control. 2006 Oct;13(4):276-85. Review.

11.

[Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].

Chebib N, Khouatra C, Lazor R, Archer F, Leroux C, Gamondes D, Thivolet-Bejui F, Cordier JF, Cottin V.

Rev Mal Respir. 2015 Nov 18. pii: S0761-8425(15)00369-1. doi: 10.1016/j.rmr.2015.10.005. [Epub ahead of print] Review. French.

PMID:
26604019
12.

Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex.

Torres VE, Björnsson J, King BF, Kumar R, Zincke H, Edell ES, Wilson TO, Hattery RR, Gomez MR.

Mayo Clin Proc. 1995 Jul;70(7):641-8. Review.

PMID:
7791386
13.

Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.

Matsui K, Tatsuguchi A, Valencia J, Yu Zx, Bechtle J, Beasley MB, Avila N, Travis WD, Moss J, Ferrans VJ.

Hum Pathol. 2000 Oct;31(10):1242-8. Review.

PMID:
11070117
14.

Primary retroperitoneal lymphangioleiomyomatosis in a postmenopausal woman: a case report and review of the literature.

Kebria M, Black D, Borelli C, Modica I, Hensley M, Chi DS.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):528-32. Review.

PMID:
17362325
15.

Lymphangioleiomyomatosis.

Johnson SR.

Eur Respir J. 2006 May;27(5):1056-65. Review.

16.

Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.

Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, Riemenschn W, Matsui K, Travis WD, Moss J.

J Nippon Med Sch. 2000 Oct;67(5):311-29. Review.

17.

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.

Krymskaya VP.

Proc Am Thorac Soc. 2008 Jan 1;5(1):119-26. Review.

18.

Management of lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

F1000Prime Rep. 2014 Dec 1;6:116. doi: 10.12703/P6-116. eCollection 2014. Review.

19.

Localized retroperitoneal lymphangioleiomyomatosis mimicking malignancy. A case report and review of the literature.

Jaiswal VR, Baird J, Fleming J, Miller DS, Sharma S, Molberg K.

Arch Pathol Lab Med. 2003 Jul;127(7):879-82. Review.

PMID:
12823048
Items per page

Supplemental Content

Write to the Help Desk